tirzepatide home delivery Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide for Medical Weight Loss

GLOW focuses more on collagen and remodeling pathways, while KLOW adds an additional research dimension with KPV for inflammation-response signaling

Designed for lasting change

A retrospective observational study published in Clinical Nutrition found that nutritional deficiencies were diagnosed in 12.7% of patients within 6 months of starting GLP-1 receptor agonists, and that number climbed to 22.4% within 12 months

Relationship strain: Decreased frequency of sex can lead to tension with partners, reduced bonding, and even higher divorce rates in some studies

These findings are consistent with data accessed on February 9, 2026